Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/16/2025

Differential Diagnosis for Left Axillary Pain and Swelling 48 Hours Post-Vaccination

Primary Differential Diagnoses

  • Vaccine-associated adenopathy occurs in up to 16% of vaccine recipients aged 18-64 years and represents the normal immune response to intramuscular deltoid injection 1, 2
  • Lymph node enlargement results from locally activated antigens that accumulate at the injection site and migrate to draining axillary and supraclavicular nodes 1, 2
  • The 48-hour timeline perfectly matches the expected onset of 2-4 days post-vaccination 1, 2, 3
  • Both influenza and herpes zoster vaccines are documented to cause regional adenopathy, with influenza vaccine specifically showing increased nodal metabolic activity on imaging 1, 2, 3
  • Clinical duration typically ranges from 1-2 days (Moderna data) to 10 days (Pfizer data), though imaging findings may persist longer 1, 2, 3
  • Pain, redness, and swelling occur in 19-38% of vaccine recipients but typically resolve within 3-14 days 4
  • Extensive limb swelling can occur in 2-3% of booster recipients, beginning within 48 hours 4
  • The reaction may extend beyond the immediate injection site to involve regional lymphatic drainage 4
  • Radial or axillary nerve damage from direct needle trauma or compression from inflammatory reaction 4
  • Direct trauma from injection or inflammatory myopathy presenting with localized pain and weakness 4

Critical Clinical Assessment Points

  • Assess for warmth, tenderness, and erythema overlying the swelling to distinguish infectious from reactive causes 5
  • Palpate for discrete lymph nodes versus diffuse tissue swelling 5
  • Evaluate for fluctuance indicating abscess formation (would require drainage) 5
  • Check for signs of systemic toxicity including fever >38°C, tachycardia, or altered mental status 5
  • Assess functional limitation: ability to perform overhead activities, lifting, and dressing 4
  • Examine the injection site itself for local reaction characteristics 4
  • Fever, systemic symptoms, or signs of toxicity suggest infection rather than reactive adenopathy 5
  • Rapidly progressive swelling beyond expected vaccine reaction timeline 5
  • Severe pain requiring prescription medication (occurred in 0.3-0.6% of vaccine recipients) 1, 2
  • Persistent symptoms beyond 2 weeks warrant imaging evaluation 1, 2, 3

Diagnostic Approach

  • Reassurance and observation are appropriate for typical vaccine-associated adenopathy presenting within 2-4 days of vaccination 1, 2, 3
  • No imaging is indicated for typical presentations in the first 1-2 weeks 1, 2, 3
  • If symptoms persist beyond 10-14 days, ultrasound is the initial imaging modality to differentiate solid lymph nodes from abscess 5
  • Laboratory testing (CBC, ESR, CRP) if infection or inflammatory process is suspected based on fever or systemic symptoms 5, 4
  • CT with contrast reserved for suspected deep space infection or when ultrasound is inconclusive 5

Important Clinical Pitfalls

  • In patients with cancer history or undergoing cancer surveillance, vaccine-associated adenopathy can mimic metastatic disease, leading to unnecessary biopsies or treatment changes 1, 2, 3
  • This is particularly relevant for breast cancer, head and neck cancers, lymphoma, and melanoma of upper extremities 1, 2, 3
  • Ideally, cancer-related imaging should be performed prior to vaccination when feasible 3
  • For routine surveillance or screening (not urgent indications), consider postponing imaging for 4-6 weeks post-vaccination 3
  • Document which arm received which vaccine, as adenopathy should be ipsilateral to the injection site 1, 2, 3
  • If both vaccines were given in the left arm, this strongly supports reactive adenopathy as the diagnosis 1, 2
  • Most vaccine reactions resolve completely within days to weeks without sequelae 1, 2, 4